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African swine fever is a haemorrhagic fever of
estic pigs and wild boar which is caused by a large
oplasmic DNA virus, African swine fever virus (ASFV).
lates of high, moderate and low virulence cause
ering levels of disease with mortality ranging from
y low to 100%. Macrophages are regarded as the
ary target cells for virus replication since at early
es, infection is mainly observed in macrophages in
vivo and has only been observed in other cells at late
stages of disease (Carrascosa et al., 1999; Rodriguez et al.,
1996). In vitro, different subpopulations of monocytes/
macrophages vary in susceptibility to ASFV infection but
there is little knowledge of the host and virus factors
which inﬂuence this. Although low levels of infection are
observed in freshly isolated bone marrow cells or blood
monocytes (McCullough et al., 1997, 1999; Sanchez-
Torres et al., 2003) efﬁcient infection is observed in
mature alveolar macrophages and in vitro maturation of
monocytes to macrophages was demonstrated to
increase susceptibility to ASFV infection. This correlates
with up-regulation of cell surface CD203a (SWC9), a
marker of mature macrophages (McCullough et al., 1999;
Sanchez-Torres et al., 2003). However, Blocking experi-
ments with monoclonal antibodies to CD203a did not
provide evidence for CD203a as a cellular receptor for the
virus (Sanchez-Torres et al., 2003).
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A B S T R A C T
The expression of surface markers on African swine fever virus (ASFV) infected cells was
evaluated to assess their involvement in infection. Previous ﬁndings indicated CD163
expression was correlated with ASFV susceptibility. However, in this study the expression
of porcine CD163 on cell lines did not increase the infection rate of these cells indicating
other factors are likely to be important in determining susceptibility to infection. On
adherent porcine bone marrow (pBM) cells the expression of CD45 was strongly correlated
with infection. CD163 and CD203a expression correlated at intermediate levels with
infection, indicating cells expressing these markers could become infected but were not
preferentially infected by the virus. Most of the cells expressing MHCII were infected,
indicating that they may be preferentially infected although expression of MHCII was not
essential for infection and a large percentage of the infected cells were MHCII negative.
CD16 showed a marked decrease in expression following infection and signiﬁcantly lower
levels of infected cells were shown to express CD16. Altogether these results suggest
CD163 may be involved in ASFV infection but it may not be essential; the results also
highlight the importance of other cell markers which requiring further investigation.
 2013 The Authors. Published by Elsevier B.V. 
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P. Lithgow et al. / Veterinary Microbiology 168 (2014) 413–419414The expression of CD163, a marker of mature macro-
phages, has previously been shown to correlate with ASFV
infection (Sanchez-Torres et al., 2003). CD163 is a member
of the scavenger receptor cysteine-rich superfamily and is
expressed on monocytes at low levels and on tissue
macrophages at high levels (Kristiansen et al., 2001;
Sanchez et al., 1999; Schaer et al., 2006). Antibodies to
CD163 were shown to reduce ASFV virion binding to
alveolar macrophages by more than 50% (Sanchez-Torres
et al., 2003). Furthermore, separation of blood monocytes
into CD163 expressing and non-expressing cells demon-
strated that permissiveness to ASFV infection correlated
with expression of CD163 (Sanchez-Torres et al., 2003).
However, in primary cells, it has been shown that ASFV can
enter CD163 cells and only a fraction of CD163+ blood
monocytes are susceptible to ASFV, indicating that
additional factors are important for virus replication
(Sanchez-Torres et al., 2003).
Additional markers used in this study include CD172a,
MHCII, CD16 and CD14, the detection of these markers
allows evaluation of the phenotype of the cells. CD172a is
expressed on all cells of myeloid lineage (Chamorro et al.,
2005). The expression of MHCII, CD16 or CD14 indicates
particular activation of the macrophages as they are
involved with antigen presentation, antibody binding and
LPS detection respectively (Marquet et al., 2011; Chamorro
et al., 2005; Carrasco et al., 2001; Ezquerra et al., 2009).
In this study we investigated the cell markers expressed
on infected macrophages to further characterise the
phenotype of susceptible cells.
2. Methods and materials
2.1. Preparation and culture of porcine bone marrow (pBM)
cells
Bone marrow derived macrophages were obtained from
cells rinsed from femur bones with PBS then overlaid onto
1077 Histopaque (Sigma, USA). A gradient was formed by
centrifugation at 400  g for 30 min (25 8C) and buffy coat
cells were removed into PBS. Cells were pelleted by
centrifugation and washed in PBS then cells were re-
suspended in Earles saline plus 10% porcine sera (PS)
(Biosera, UK) supplemented with 200 U ml1 penicillin and
200 mg ml1 streptomycin and cultured in plastic ﬂasks or
plates at 37 8C with 5% CO2. Non-adherent cells were
removed after 2 h and cells were cultured for a further 6–7
days.
2.2. Continuous cell lines
Vero, and PK15 cells, plus cells received from Pﬁzer
Kalamazoo, USA, PK0809, PK9 (express porcine CD163),
NLFK-1, FKD4 (express simian CD163) (Calvert et al., 2007)
were grown in DMEM medium supplemented with 10%
foetal calf serum and antibiotics.
2.3. Virus isolates, titrations and infection
ASFV isolates used for infections were BA71v (tissue
culture adapted), Attenuated Uganda (tissue culture
adapted), Benin 97/1 (high virulence ﬁeld isolate) and
Virulent Uganda (high virulence ﬁeld isolate).
Field isolates and tissue culture adapted isolates were
propagated on pBM cells and Vero cells respectively then
puriﬁed from cell supernatants using Optiprep gradients
(Zhang et al., 2006). Virus stocks were titrated by limiting
dilution either in pBM cells, using haemadsorption to
detect ﬁeld isolates or in Vero cells by immunoﬂuores-
cence as described below for tissue culture-adapted
isolates (Goatley and Dixon, 2011; Malmquist and Hay,
1960; OIE, 2007).
For infections virus inoculum was added to the cells in
serum free medium. Cells were incubated at 37 8C for 1–
2 h; the diluted virus inoculum was then removed and
replaced with growth medium supplemented with 10%
serum and antibiotics (Vector Laboratories, USA), and
viewed on a confocal microscope, Leica TCSSP2.
2.4. Detection of CD163 by reverse transcriptase polymerase
chain reaction (RT-PCR)
CD163 was detected by RT-PCR, primers were designed
to a region of coding sequence of CD163 that is conserved
between human, mouse and pig and a conserved region of
GAPDH as a positive control. RT-PCR ampliﬁcations were
performed in 20 ml reaction volumes, using a Onestep RT-
PCR kit (Qiagen) following the manufacturer’s guidelines.
Reaction mixtures included 0.2 mM ml1 of each primer
(CD163 forward GGGGACTGAAAGAAGCTGATGT, reverse
CCCTCACACTGGAATTCTTCAGCCC, expected product
436 bp; GAPDH forward GCCATCAATGACCCCTTCATTG,
reverse TCTTCTGGGTGGCAGTGATGGC, expected product
465 bp) and a variable amount of template RNA (250 ng).
2.5. Stable expression of CD163 on PK15 cells
Exogenous porcine CD163 was stably expressed in PK15
cells, by transfection of a plasmid expressing the full length
porcine CD163, pIRESneoCD163. Cells were transfected
with pIRESneoCD163 (coding region for CD163 in pcDNA3
received from the National Institute, INIA, Spain and
cloned into pIRESneo data not shown) using TransIT-LTI
(Mirus, USA) according to the manufacturer’s recommen-
dations. Following transfection, cells were incubated for
18–24 h at 37 8C and 5% CO2. Stable expression of CD163
was maintained under G418 selective pressure. Cells
expressing CD163 on the surface were puriﬁed by
magnetic selection, positive selection of cells was achieved
using the MACS MS column (Miltenyi Biotec, UK), to select
cells positive for CD163. Cells were incubated with
15 ng ml1 anti CD163 primary mouse mAb (2A10, INIA,
Spain (Sanchez-Torres et al., 2003)) for 15 min on ice. The
cells were then washed three times using serum free
DMEM then incubated with goat-anti-mouse-IgG coated
micro beads (Miltenyi Biotec) for up to 1 h on ice. Cells
were washed three times in MACS buffer and resuspended
in 0.5 ml of MACS buffer and positively selected by passing
through a MS positive selection column (Miltenyi Biotec).
Selected cells were pelleted at 100  g for 5 min. Cells were
then resuspended in cell medium and seeded into T25
ﬂasks or processed for limiting dilution.
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Cells were grown on 13 mm coverslips in 24-well
tes. Cells at different times-post-infection or mock-
cted were ﬁxed for 20 min in 4% paraformaldehyde
n permeabilised in Ca2+/Mg2+ free PBS containing 0.2%
on X-100 for 5 min at room temperature. After washing
 blocking in Ca2+/Mg2+ free PBS containing 0.2% BSA
S/BSA) cells were incubated with primary antibody
30/CP204L, C18 IgG1 (IAH, UK)) followed by secondary
ibody (goat anti mouse IgG1 Alexa-Fluor 568, Invitro-
, USA). The coverslips were mounted with Vectasheild
taining DAPI.
 Flow cytometric analysis
Cells were analysed for surface markers by ﬂow
ometric analysis using the lysis II program on the
Scalibur1 (Becton Dickinson, UK). 2  105 cells were
d in 4% paraformaldehyde, permeabilised in Ca2+/Mg2+
 PBS containing 1% TW20 for 20 min at room
perature and incubated with 20 ml of primary mono-
al antibodies (VP72, 4H3, IgG2a (Cobbold and Wile-
n, 1998); CD45, K2521.E4 (IAH UK): CD163 [2A10, INIA,
in (Sanchez-Torres et al., 2003)]: CD203a [C4, IAH UK];
CII [K274.3GB, AbD serotec UK]; CD16 [G7, Becton
kinson, USA], all IgG1) for 10 min at room temperature.
y were then washed twice with FACS buffer (FB, PBS,
% (w/v) NaN3, 2% (v/v) goat serum, 0.3% (w/v) bovine
um albumin), and incubated with isotype speciﬁc goat
i-mouse IgG2a antibody conjugated to Alexa-Fluor 488
 goat anti-mouse IgG1 antibody conjugated to Alexa-
or 633 for 10 min at room temperature, followed by a
her two washes with FB. Cells were ﬁxed in 1% PFA and
lysed or stored at 4 8C.
esults
 Evaluation of CD163 involvement in ASFV infection
1. Expression of CD163 in porcine cells
Porcine CD163 has previously been suggested as a
ative receptor for ASFV. In order to determine if
ression of porcine CD163 on the surface of cell lines
 expressing CD163 could increase their susceptibility to
ction by ASFV we constructed cells lines stably
ressing CD163. As a ﬁrst step several cell lines were
ayed for expression of CD163 by RT-PCR. Endogenous
63 mRNA was detected by RT-PCR in porcine macro-
ges and Vero cells, but no CD163 mRNA expression was
ected in the porcine kidney cell line PK15 (data not
wn). Therefore PK15 cells were selected for further
dies. Exogenous porcine CD163 (plasmid pIRES-
CD163) was stably expressed in PK15 cells. The
ression of CD163 on three clones of PK15 cells
signated PK15CD163) was conﬁrmed by immunoﬂuor-
ence and FACS (Fig. 1).
2. Evaluation of ASFV infection of cells express CD163
Experiments were carried out to determine if cell
face expression of CD163 either conferred susceptibility
to infection with ASFV ﬁeld isolates which usually do not
infect stable cell lines without adaptation. The effect of cell
surface expression of porcine CD163 on replication of
tissue-culture adapted ASFV was also evaluated. Cells
expressing porcine CD163 (PK15CD163, PK9) or simian
CD163 (FKD4) and control parental cells (PK15, PK0809
and NLFK-1) were infected with a tissue-culture adapted
ASFV isolate, Attenuated Uganda, which replicates in PK15
cells, or with isolates which do not replicate in PK15 cells
(data not shown). These isolates included ﬁeld isolates
Benin 97/1 and Virulent Uganda, which replicate in
primary macrophages but not PK15 cells and the Vero
cell adapted BA71V isolate. Vero cells and cultured pBM
cells were also infected as positive controls for infections
with BA71V and ﬁeld isolates respectively.
PK15, PK15CD163 (3 clones), PK0809, PK9, NLFK-1
FKD4, Vero cells and adherent cultured pBM cells, were
infected at a high multiplicity of infection (MOI-10) with
ASFV isolates Benin 97/1, Virulent Uganda, BA71V or
Attenuated Uganda. At twenty-four hpi adherent cells
were ﬁxed and ASFV early viral protein VP30 was
visualised by immunoﬂuorescence. Expression of ASFV
VP30 is generally observed from about 2 to 4 h post-
infection then continually throughout the infection cycle
(data not shown). Therefore, detection of cells expressing
VP30 indicates that the virus has entered and uncoated and
that early virus gene expression has started.
Following infection with the Benin 97/1 or Virulent
Uganda ﬁeld isolates, expression of VP30 was detected in
50  0.5% and 24  8% of pBM cells and in 26  3% and
0.3  0.3% of Vero cells respectively (Fig. 2). A very low
percentage of cells expressing VP30 were detected following
Benin 97/1 or Virulent Uganda infection of all other cells.
There was no statistical difference in the percentage of cells
which expressed VP30 following infection with the ﬁeld
isolates between the parental cells and cells expressing
exogenous CD163.
The percentage of cells expressing VP30 after infection
with BA71V or Attenuated Uganda did not differ sig-
niﬁcantly between parental cell lines and cell lines
expressing CD163 (Fig. 2). Thus, expression of exogenous
cell surface porcine CD163 did not signiﬁcantly increase
the percentage of cells which could be infected with either
ﬁeld isolates or tissue-culture adapted ASFV isolates.
3.2. Evaluation of macrophage surface markers associated
with infection
Flow cytometric analysis was used to assess expression
of ASFV late viral protein VP72 (B646L) and a range of
macrophage surface markers (CD45, CD163, CD203a,
MHCII and CD16). The VP72 protein is expressed only at
late times post-infection thus its expression demonstrates
that virus replication has occurred to this stage. pBM cells
were cultured for 6 days in the presence of porcine serum,
to allow maturation, before infection with virulent ASFV,
Benin 97/1 isolate (Nix et al., 2006) at a high multiplicity of
infection (MOI-10). At 24 h post-infection (hpi), adherent
pBM cells were processed for ﬂow cytometric analysis with
mouse anti VP72 mAb and mouse anti-cell surface marker
mAb (CD45, CD163, CD203a, MHCII, CD16).
P. Lithgow et al. / Veterinary Microbiology 168 (2014) 413–419416The percentage of cells expressing the cell surface
markers and the intensity of expression, mean ﬂuorescence
intensity (MFI, measured using geometric mean) was
compared in mock-infected cells and infected cells
(Fig. 3). Following ASFV infection, the intensity of expression
and percentage of cells expressing CD45, CD203a or MHCII
was not signiﬁcantly different compared to mock-infected
pBM cells (percentage: [CD45: infected cells, 80  0.5%;
mock-infected cells, 74  18%] [CD203a: infected cells,
49  17%; mock-infected cells, 42  18%] [MHCII: infected
cells, 16  12%; mock-infected cells, 13  4%]; MFI: [CD45:
infected cells, 13  3; mock-infected cells, 11  2] [CD203a:
infected cells, 16  7; mock-infected cells, 10  4] [MHCII:
infected cells, 2  2; mock-infected cells, 2  1]). In contrast
the proportion of cells expressing, CD163+ (infected cells:
30  12%; mock-infected cells: 40  9%) and CD16+ (infected
cells: 11  7%; mock-infected cells: 63  4%) (p = 0.02) were
reduced after ASFV infection (Fig. 3A). The intensity of CD16
expression was also reduced following infection (MFI, infected
cells: 2  2; mock-infected cells: 9  3) (Fig. 3B).
3.2.1. Evaluation of macrophage marker expression on ASFV
infected cells
The proportion of cells expressing each marker
expressed within the VP72 positive cell population was
calculated (surface marker positive with VP72 positive/
total VP72 positive  100) (Fig. 3C). This allowed evalua-
tion of whether VP72 expression (indicating infection) is
restricted to cells expressing any particular marker. A very
high proportion of VP72 expressing cells also expressed
CD45 (89  6%). The proportion of VP72 expressing cells
which also expressed CD163 (39  16%) or CD203a
(54  18%) was intermediate. This indicates that cells
expressing these markers could be infected, although
infection was not dependent on expression of these markers.
Within the population of cells expressing VP72, the propor-
tion of MHCII+ and CD16+ cells was low (MHCII: 22  17%;
CD16: 6  5%).
3.2.2. Evaluation of ASFV infection within populations of cells
expressing speciﬁc markers
To evaluate which cells positive for each marker were
infected with ASFV the proportion of cells expressing each
marker which were infected was calculated (surface
marker positive with VP72 positive/total marker
positive  100) (Fig. 3D). Almost three quarters of the
CD45+ and MHCII+ cells expressed VP72 (CD45: 70  6%;
MHCII: 75  8%) and more than half of the CD163+ or
CD203a+ cells expressed VP72 (CD163: 67  10%; CD203a:
57  7%). This indicates that CD45+ and MHCII+ cells are
Fig. 1. Analysis of CD163 expression on PK15 cells. pBM cells cultured for 6 days, Vero, PK15, and PK15CD163 cells were assessed for the expression of total
CD163 in permeabilised cells and on the surface of non-permeabilised cells. Expression was assessed by ﬂow cytometric analysis following staining with
mouse anti-porcine CD163 mAb (2A10) and goat anti-mouse Alexa-Fluor 633 conjugated antibody.
Fig. 2. VP30 expression detected in cells with or without CD163 following ASFV infection. pBM cells were cultured for 6 days, Vero, PK15, PK15CD163,
PK0809, PK9 (CD163+), NLFK1 and FKD4 (CD163+) cells (173  6 cells per replicate) were assessed for percentage of cells expressing ASFV VP30 following
infection. ASFV isolates Benin 97/1, Virulent Uganda, BA71V or Attenuated Uganda were added at an MOI-10. Twenty-four hpi cells were ﬁxed and permeabilised.
Expression of intracellular antigen was estimated by staining with a mouse anti-VP30 mAb (C18) and goat anti mouse Alexa-Fluor 568 conjugated antibody. The
virus strain used for infections is indicated under the x axis which also shows the cells infected. The y axis shows the percentage of infected cells. Bars show the
average percentage positive cells and standard error (SE). Results show mean and standard error from 1 to 8 experiments.
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P. Lithgow et al. / Veterinary Microbiology 168 (2014) 413–419418strongly associated with infection and that CD163+ and
CD203a+ cells can become infected but the expression of
these markers is not necessary for infection. Only a ﬁfth of
CD16+ cells expressed VP72 (19  12%); which is signiﬁcantly
lower than cells expressing CD45 (p = 0.07), MHCII (p = 0.04)
or CD163 (p = 0.04).
4. Discussion
In these experiments one aim was to determine if cell
surface expression of porcine CD163could increase sus-
ceptibility of cell lines to infection with ASFV isolates.
Previous work had suggested that CD163 expression
correlated with susceptibility to ASFV infection and that
CD163 may be a receptor for ASFV. However no signiﬁcant
differences were observed when cell lines stably expres-
sing CD163, or the parental cell lines were infected with
either virulent ﬁeld ASFV isolates or tissue-culture adapted
ASFV isolates. This indicates that CD163 expression alone
is not sufﬁcient to increase ASFV infection in cells that are
not susceptible to infection. ASFV infection and replication
necessary to form a receptor complex as well as
intracellular factors required for the virus replication
cycle. Thus our data does not exclude the possibility that
CD163 plays a role in ASFV infection. Previous experiments
showed that if cells were treated with antibodies to CD163,
ASFV infection was signiﬁcantly decreased (reduced by
50%). A possible explanation for these ﬁndings is that
binding of ASFV to CD163 is necessary for some virus
infection. However, there are other possibilities such as
blocking of virus interaction with other cell surface
receptors by the anti-CD163 antibody.
ASFV replicates in cells of monocyte/macrophage
lineage and variable infection rates have been reported
suggesting that subsets of these cells differing in activation
or differentiation state are preferentially infected (McCul-
lough et al., 1999; Sanchez-Torres et al., 2003). Although
cell surface expression of CD163 was suggested previously
to correlate with ASFV infection (Sanchez-Torres et al.,
2003), it was shown that CD163 cells were susceptible to
ASFV infection (Sanchez-Torres et al., 2003) and results
presented here also show substantial cell numbers in the
Fig. 3. Effect of ASFV infection on cell marker expression of cultured pBM cells. pBM cells were cultured for 6 days then infected for 24 h with ASFV Benin 97/
1 (MOI-10). Expression of VP72 (B646L), CD45 (K2521.E4), CD203a (C4), CD163 (2A10), CD16 (G7), and MHCII (K274.3GB) was assessed on adherent pBM
cells by ﬂow cytometric analysis. (A) shows marker expression calculated as percent positive events (Overton subtraction method). (B) shows the increase
in mean ﬂuorescence intensity (MFI). (C) shows the proportion of each marker expressed within the VP72 positive cell population (marker positive with
VP72 positive/total VP72 positive  100). (D) shows the proportion of cells expressing each marker which expressed VP72 (marker positive with VP72
positive/total marker positive  100). Results show mean and standard errors from two to four experiments (*p  0.05).CD163 population are also susceptible to ASFV infectionin these cells may require other molecule(s) such as those
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iﬁcant change in CD163 expression was observed
ing the course of infection indicating that the CD163
cted cells did not derive from down-regulation of
63 after infection. It is important to note that the
sent study utilised cells which had been cultured for 6
s to produce a mature macrophage phenotype which is
re similar to the in vivo target for ASFV than the blood
nocytes used in the study by Sanchez-Torres et al.
03). This could in part explain variations in the total
el of CD163 cells observed and infected with ASFV.
Our results also showed that intermediate proportions
ells expressing CD45, CD203a were infected with ASFV.
s, cells expressing these markers could become
cted but were not preferentially infected by the virus.
st of the cells expressing MHCII were infected indicat-
 that these cells may be preferentially infected.
ever, the MHCII+ cells represent a small proportion
hin the total infected cell population and thus expres-
 of MHCII is not essential for infection. In contrast CD16
wed a marked decrease in expression following
ction and signiﬁcantly lower percentages of infected
s were shown to express CD16 compared with the total
 population.
The dramatic decrease in CD16 expression in infected
s and the lack of ASFV infection in CD16+ cells indicates
t either expression of CD16 is abrogated following ASFV
ction and/or the population of CD16+ cells are lost from
 culture by cell death. If ASFV infection results in down-
ulation of CD16 expression this could potentially
act on the function of the cells. Although Sanchez
al. (1999) reported most porcine monocytes and
crophages express CD16, human monocytes/macro-
ges have subsets of either CD16+ or CD16 cells; CD16
nocytes/macrophages were shown to be more
uno-stimulatory and CD16+ monocytes/macrophages
re shown to be more cytotoxic (Wang et al., 2001;
gler-Heitbrock, 2007). Whether such subpopulations of
nocytes/macrophages exist in pigs and differ in their
ction or susceptibility to ASFV infection is not clear and
uires further investigation.
The work presented here shows ASFV infection
relates with the expression of speciﬁc cell markers
 previously identiﬁed and suggests these are indicators
cells which have a cellular environment suited to ASFV
lication. Further studies are required to continue the
estigation into the association of markers and ASFV
ction, the experiments presented here evaluated
ulations of cells produced under a single culture
dition. Analysis of macrophages activated in different
ys to evaluate changes in marker expression and how
 impacts ASFV infection is needed to strengthen the
ociation and possible involvement of the different
rkers discussed here. Knowledge of the cellular markers
ociated with ASFV infection will only improve under-
ding of the virus interaction with host cells and how
 impacts on pathogenesis and immune evasion. In
ition this could provide information leading to devel-
ent of improved cell lines for ASFV replication which
uld have applications in virus diagnosis and vaccine
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